Blood substitute of hemoglobin microcapsule and preparing method thereof

A technology of blood substitutes and hemoglobin, which is applied in the field of hemoglobin microcapsule blood substitutes and its preparation, can solve the problems of low concentration of embedded hemoglobin, easy peroxidation of phospholipids, and poor stability, so as to improve the embedding rate and facilitate amplification , the effect of reducing particle size

Inactive Publication Date: 2003-05-28
INST OF PROCESS ENG CHINESE ACAD OF SCI
View PDF1 Cites 12 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, hemoglobin liposomes still have the following disadvantages: poor stability during storage and after infusion; phospholipids have potential effects on the reticuloendothelial system; phospholipids are p

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0041] Example 1:

[0042] Dissolve 50mg 30,000 (5000) (PLA / MPEG molecular weight is 30,000, of which MPEG molecular weight is 5000, the same below) dissolved in 3ml dichloromethane, add 600ul bovine hemoglobin, colostrum at 10000rpm for 30s, pour 100ml NaCl 0.9%, PVA6 % Double emulsion, re-emulsify at 8000 rpm for 1 min, then pour it into 200 ml of physiological saline, and stir magnetically at 1000 rpm under normal temperature and pressure for 1.5 hours. Finally, centrifugation and washing four times with 10000g physiological saline to collect the hemoglobin microcapsule precipitation. (The weight ratio of copolymer and hemoglobin in the microcapsules is 1:2, and the particle size is less than 4 μm).

Example Embodiment

[0043] Example 2:

[0044] Dissolve 40mg 60 thousand (5000) in a mixed solvent of 2ml dichloromethane and 1ml ethyl acetate, add 800ul hemoglobin, colostrum at 10000rpm for 30s, pour into 100ml 1% glycerol, PVA6% double emulsion, re-emulsify at 8000rpm for 1min, Then pour it into 200ml of normal saline and stir it magnetically at 1000rpm under normal temperature and pressure for 1.5 hours. Finally, centrifugation and washing four times with 10000g physiological saline to collect the hemoglobin microcapsule precipitation. (The weight ratio of copolymer and hemoglobin in the microcapsules is 1:3, and the particle size is less than 4 μm).

Example Embodiment

[0045] Example 3:

[0046] Dissolve 20mg 20 thousand (1000) and 30mg 60 thousand (10000) in 3ml dichloromethane, add 600ul hemoglobin, 12000rpm colostrum for 30s, pour into 100ml 2% glucose, PVA4% double emulsion, re-emulsify at 10000rpm for 1min, then pour Into 200ml of 2% glucose aqueous solution, magnetic stirring at 1000rpm under normal temperature and pressure for 1.5 hours. Finally, it was centrifuged and washed four times with physiological saline at 12000g to collect the hemoglobin microcapsule precipitate. (The weight ratio of copolymer and hemoglobin in the microcapsules is 1:2, and the particle size is less than 3μm).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Particle sizeaaaaaaaaaa
Login to view more

Abstract

A haematoglobin microsoft capsule as the blood substitute contains the copolymer of one or more polylactic acids and monomethoxy polyethanediol and haematoglobin, and is prepared through dissolving said copolymer in organic solvent, dissolving haematoglobin in it, high-speed homogenizing or ultrasonic dispersing to generate W1/O emulsion, adding it to re-emulsifier, high-speed homogenizing or ultrasonic dispersing to become W1/O/W2 re-emulsion, adding to solidifying liquid, removing organic solvent, centrifugal washing and collecting haematoglobin microsoft capsules.

Description

field of invention [0001] The invention belongs to the field of biomedicine, in particular to a hemoglobin microcapsule blood substitute and a preparation method thereof. Background technique [0002] Nowadays, the shortage of clinical blood sources and cross-infection of blood have become a worldwide problem. Seeking safe and effective blood substitutes has become a research and development hotspot in the field of international medical biotechnology. [0003] The hemoglobin molecule is a tetramer composed of 2 α subunits and 2 β subunits, with a diameter of 5.5 nm and a molecular weight of 64,500 dal. Hemoglobin and O 2 The binding is reversible. The oxygen affinity of hemoglobin refers to the firmness of hemoglobin to oxygen binding, which is expressed by the partial pressure of oxygen required for the oxygen in hemoglobin to reach half-saturation, denoted as P 50 . The combination and release of oxygen by hemoglobin is a highly coordinated a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K38/42A61P7/08A61P43/00
Inventor 苏志国孟凡涛赵东旭
Owner INST OF PROCESS ENG CHINESE ACAD OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products